Showing results (121-130 of 192) with videos related to

Sort By:
Pageof 20
Carcinogenesis|August 25, 2010
Hypertension, diuretics and antihypertensives in relation to bladder cancerXuejuan Jiang, J Esteban Castelao, Jian-Min Yuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trialSilvia C Formenti, Matthew Volm, Kristin A Skinner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancerJan Brabender, Kathleen D Danenberg, Ralf Metzger, et al.
BJU International|November 22, 2014
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trialFriedrich-Carl von Rundstedt, Douglas A Mata, Susan Groshen, et al.
Breast Cancer Research and Treatment|July 10, 2026
Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer riskJacob G Comeaux, Natalia Gutierrez, Charité N Ricker, et al.
The Journal of Biological Chemistry|October 22, 2002
Ceramide signaling in fenretinide-induced endothelial cell apoptosisAnat Erdreich-Epstein, Linda B Tran, Nina N Bowman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2019
Phase 1 Trial of SBRT to the Prostate Fossa After ProstatectomyLeslie K Ballas, Chunqiao Luo, Eugene Chung, et al.
Anticancer Research|April 4, 2008
Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancerRyutaro Mori, Qingcai Wang, Marcus L Quek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2014
Phase I, dose-escalation study of the targeted cytotoxic LHRH analog AEZS-108 in patients with castration- and taxane-resistant prostate cancerStephen V Liu, Denice D Tsao-Wei, Shigang Xiong, et al.
Cancer Research|March 21, 2014
Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasivenessGillian H Little, Sanjeev K Baniwal, Helty Adisetiyo, et al.
Pageof 20